These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16456108)

  • 1. Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction?
    Hajjar RJ; Leopold JA
    Circ Res; 2006 Feb; 98(2):169-71. PubMed ID: 16456108
    [No Abstract]   [Full Text] [Related]  

  • 2. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
    Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
    Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase inhibitors: an emerging class of drugs for heart failure.
    Kittleson MM; Hare JM
    Eur Heart J; 2005 Aug; 26(15):1458-60. PubMed ID: 15917281
    [No Abstract]   [Full Text] [Related]  

  • 4. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
    Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
    Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
    Harzand A; Tamariz L; Hare JM
    Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Xanthine Oxidase Inhibitors Improve Cardiac Function in Patients With Chronic Heart Failure?
    Sugihara S; Yamamoto K; Hisatome I
    Int Heart J; 2016 Dec; 57(6):661-662. PubMed ID: 27818485
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy.
    Duncan JG; Ravi R; Stull LB; Murphy AM
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1512-8. PubMed ID: 15863459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of urate and xanthine oxidase inhibitors in cardiovascular disease.
    George J; Struthers AD
    Cardiovasc Ther; 2008; 26(1):59-64. PubMed ID: 18466421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febuxostat, a nonpurine selective inhibitor of xanthine oxidase: a promising medical therapy for chronic heart failure?
    Gao LG; Yao XP; Zhang L; Wen D; Luo F; Zhou XL; Hui RT
    Chin Med J (Engl); 2010 Sep; 123(17):2471-4. PubMed ID: 21034568
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME; Cotter MA; Cameron NE
    Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A renaissance of positive inotropic interventions to treat heart failure?
    Neumann J
    Cardiovasc Res; 2003 Sep; 59(3):534-5. PubMed ID: 14499853
    [No Abstract]   [Full Text] [Related]  

  • 12. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy.
    Cappola TP; Kass DA; Nelson GS; Berger RD; Rosas GO; Kobeissi ZA; Marbán E; Hare JM
    Circulation; 2001 Nov; 104(20):2407-11. PubMed ID: 11705816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters.
    Hayashi K; Kimata H; Obata K; Matsushita A; Fukata A; Hashimoto K; Noda A; Iwase M; Koike Y; Yokota M; Nagata K
    J Card Fail; 2008 Apr; 14(3):238-44. PubMed ID: 18381188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.
    Cingolani HE; Plastino JA; Escudero EM; Mangal B; Brown J; Pérez NG
    J Card Fail; 2006 Sep; 12(7):491-8. PubMed ID: 16952781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Allopurinol on Myocardial Energy Metabolism in Chronic Heart Failure Rats After Myocardial Infarct.
    Wang Z; Ding J; Luo X; Zhang S; Yang G; Zhu Q; Liu D
    Int Heart J; 2016 Dec; 57(6):753-759. PubMed ID: 27818481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
    Doehner W; Anker SD
    Heart; 2005 Jun; 91(6):707-9. PubMed ID: 15894755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ongoing search for a stratified medicine approach in heart failure.
    Tang WH
    J Am Coll Cardiol; 2008 Jun; 51(24):2310-2. PubMed ID: 18549914
    [No Abstract]   [Full Text] [Related]  

  • 18. Allopurinol and endothelial function in heart failure: future or fantasy?
    Landmesser U; Drexler H
    Circulation; 2002 Jul; 106(2):173-5. PubMed ID: 12105153
    [No Abstract]   [Full Text] [Related]  

  • 19. Xanthine oxidase inhibitors suppress testicular germ cell apoptosis induced by experimental cryptorchidism.
    Kumagai A; Kodama H; Kumagai J; Fukuda J; Kawamura K; Tanikawa H; Sato N; Tanaka T
    Mol Hum Reprod; 2002 Feb; 8(2):118-23. PubMed ID: 11818514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood antioxidant capacity in gout].
    Tsutsumi Z; Yamamoto T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():465-9. PubMed ID: 12629767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.